Gary G Chiang

6PUBLICATIONS
19CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Jacob A Boyer, Ezra Y Rosen, Malvika Sharma

|Oct 10, 2020
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.

Peggy A Thompson, Boreth Eam, Nathan P Young

|May 30, 2020
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.

Justin T Ernst, Peggy A Thompson, Christian Nilewski

|Mar 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

Siegfried H Reich, Paul A Sprengeler, Gary G Chiang

|Jan 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.

Yupeng He, Sujatha Selvaraju, Michael L Curtin

|Jan 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.

Kenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay

Pageof 1

Frequent Collaborators

2 joint publications

Siegfried H Reich

1 joint publications

Creighton T Tuzon

1 joint publications

Gunnar Schotta

1 joint publications

Justin T Ernst